Research Capital analyst Andre Uddin maintained his “Buy” rating and C$2.90 price target on Covalon Technologies (Covalon Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:COV) in a February 25 healthcare update, following what he characterized as a soft fiscal first quarter. Covalon reported Q1 fiscal 2026 revenue of $6.9-million for the period ended Dec. 31, […]
“The biggest Liberation Day winner”. That’s where Citi analyst James Hardiman thinks BRP (BRP Stock Quote, Chart News, Analysts, Financials TSX:DOO) stands in the North American travel and leisure sector. As reported by The Globe and Mail, the analyst April 4 raised his rating on BRP from “Sell” to “Neutral”, and raised his price target […]
Share
Tweet
Share
